Company news

Almirall SA news in 2025

Almirall SA's news releases, calls and decks from 2025, newest first.

View company

Almirall’s 2025 9M Results

November 10, 2025

Almirall Presents Long‑Term Results from First Real‑World Dermatology Study Using WHO‑5 Well‑Being Index as Primary Endpoint in the treatment of Psoriasis at EADV 2025

September 18, 2025

EADV 2025: Almirall Advances Skin Science and Leads Innovation for Holistic Patient Care in Medical Dermatology

September 17, 2025

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

August 12, 2025

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

August 7, 2025

Almirall H1 2025 Results, Almirall Continues to Deliver on its Long-Term Growth Strategy with Net Sales Growth of 12.7% in H1 2025, Driven by a Strong European Dermatology Business and Increasing Biologics Sales

July 28, 2025

Almirall H1 2025 Results

July 25, 2025

Almirall Q1 2025 Results

May 12, 2025

Almirall's 16th Skin Academy Brings Together Leading Experts to Advance Skin Science and Treatment Options in Medical Dermatology

March 21, 2025

AAD 2025: Almirall presents early-stage pipeline progress and real-world evidence on demonstrating AK treatment success and patient satisfaction with Tirbanibulin

March 7, 2025

Almirall Announces CFO Transition Plan and Appoints Jon U. Garay Alonso as CFO to Succeed Mike McClellan in August 2025

March 6, 2025

Almirall surpassed guidance for 2024, entering an era of sustained growth and further advancing its Medical Dermatology pipeline

February 25, 2025

Almirall 2024 Full-Year Results: Almirall Surpassed Guidance for 2024 - Entering an Era of Sustained Growth and Further Advancing Its Medical Dermatology Pipeline

February 24, 2025

Calls in 2025

Decks in 2025